Dezocine combined with flurbiprofen axetil versus sufentanil for patientcotrolled analgesia: a meta analysis

Peng CHEN,Ben-hong ZHOU,Fu-chao CHEN,Jie-xin LEI

DOI: https://doi.org/10.7539/j.issn.1672-2981.2019.02.005

2019-01-01

Abstract:Objective To evaluate the efficacy and safety of dezocine combined with flurbiprofen axetil versus sufenta for patient-controlled analgesia (PCA) . Methods The randomized controlled trials of dezocine combined with flurbiprofen axetil for PCA were gathered from PubMed, Web of science, Embase, Cochrane library, CNKI, VIP, Wan Fang and CBMdisc Data. After data extraction and quality assessment of the included RCTs, Rev Man 5.3 software was used in the meta-analysis. Results Eleven trials comprising 936 patients were included in the meta-analysis. (1) Compared with the sufentanil group, the visual analog scale (VAS) score of the combination group had significant differences at 4-hour and 8-hour post-operation; (2) Compared with the sufentanil group, the ramsay sedation score at 24-hour and 48-hour had significant differences when dezocine was combined with flurbiprofen axetil (WMD = 0.05, 95％CI (0.01, 0.10), P = 0.02) ; (3) As for the effective number of press in the PCA, the combined group was better than the single sufentanil group at 24 h and 48 h [WMD =-1.45, 95％CI (-6.04, 3.01), P < 0.01; WMD =-1.52, 95％CI (-6.20, 3.18), P < 0.01]; (4) Comparision of adverse reactions in the combination group with those of the single sufentanil group, nausea and vomiting, skin itching and incidences of adverse reaction were all significantly decreased. ConclusionAccording to domestic evidence, dezocine combined with flurbiprofen axetil for PCA may more effectively alleviate post-operative pain than sufentanil alone, and can reduce the incindence of adverse reactions.